Urologix Inc (ULGX) financial statements (2021 and earlier)

Company profile

Business Address 14405 21ST AVE N
MINNEAPOLIS, MN 55447
State of Incorp. MN
Fiscal Year End June 30
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12
Cash and cash equivalents12
Receivables12
Inventory, net of allowances, customer advances and progress billings12
Inventory12
Prepaid expense and other current assets0
Other undisclosed current assets00
Total current assets:47
Noncurrent Assets
Inventory, Noncurrent01
Property, plant and equipment01
Intangible assets, net (including goodwill)15
Goodwill 3
Intangible assets, net (excluding goodwill)12
Other noncurrent assets0
Prepaid expense and other noncurrent assets0
Total noncurrent assets:26
TOTAL ASSETS:613
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11
Employee-related liabilities01
Taxes payable00
Accounts payable and other accrued liabilities11
Debt1 
Deferred revenue and credits00
Other liabilities01
Other undisclosed current liabilities21
Total current liabilities:43
Noncurrent Liabilities
Long-term debt and lease obligation55
Long-term debt, excluding current maturities55
Liabilities, other than long-term debt 0
Deferred tax liabilities, net 0
Other undisclosed noncurrent liabilities44
Total noncurrent liabilities:89
Total liabilities:1312
Stockholders' equity
Stockholders' equity attributable to parent(7)0
Common stock00
Additional paid in capital119119
Accumulated deficit(127)(119)
Total stockholders' equity:(7)0
TOTAL LIABILITIES AND EQUITY:613

Income statement (P&L) ($ in millions)

6/30/2014
6/30/2013
Revenues
(Revenue, Net)
1417
Cost of revenue(8)(8)
Gross profit:68
Operating expenses(13)(12)
Operating loss:(7)(4)
Nonoperating income (expense)
(Foreign Currency Transaction loss, before Tax)
(0)(0)
Interest and debt expense 0
Loss from continuing operations before equity method investments, income taxes:(7)(4)
Other undisclosed loss from continuing operations before income taxes(1)(1)
Loss from continuing operations before income taxes:(8)(4)
Income tax expense (benefit)0(0)
Net loss available to common stockholders, diluted:(8)(4)

Comprehensive Income ($ in millions)

6/30/2014
6/30/2013
Net loss:(8)(4)
Comprehensive loss, net of tax, attributable to parent:(8)(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: